Frequently Asked Questions
The global life science instrumentation market is to account for USD 114.39 billion registering a CAGR of around 7.35%, in the forecast period by 2028.
The major players operating in the life science instrumentation market report are Agilent Technologies, Inc., BD, QIAGEN, Bio-Rad Laboratories, Inc., Bruker, Danaher, Eppendorf AG,Cytiva,Hitachi High-Tech Corporation, HORIBA, Ltd.,Merck KGaA, PerkinElmer, Inc., Thermo Fisher Scientific, Inc.,GENERAL ELECTRIC COMPANY, Shimadzu Corporation, Waters Corporation,bioMérieux SA,JEOL Ltd.,Tecan Trading AG and Sigma Laborzentrifugen GmbH
The high cost of instruments, lack of skilled professionals along with technical limitations related with qPCR and dPCR techniques and high cost of advanced microscopes will curb the growth of the life science instrumentation market
Life science instrumentation market is segmented on the basis of technology, application and end user.
The increasing incidence of target infectious diseases and genetic disorders is amongst the important factors intensifying the growth and demand for life science instrumentation market
